ALK and Miyoshi myopathy: The mTOR inhibitor rapamycin especially has proven efficient in sensitizing human GC-resistant T-ALL, B-ALL, MM, and NPM-ALK+ (nucleophosmin-anaplastic lymphoma kinase)-DLBCL to GC-induced apoptosis [110–117].